FibroBiologics, Inc. - Common Stock Q2 EPS $(0.66) Beats $(0.72) Estimate
FibroBiologics, Inc. - Common Stock (NASDAQ:FBLG) reported quarterly losses of $(0.66) per share which beat the analyst consensus estimate of $(0.72) by 8.33 percent. This is a 72.5 percent increase over losses of
FibroBiologics lost less money per share than experts thought it would—that's better news than expected. When a company doing research loses less money than people predicted, it hints the team might be spending smartly, which is worth watching.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.